Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2009-04-09

Clinical Trial Update: Feasibility Trial of Traumatic Brain Injured Patients Randomized in the Prehospital Setting to Either Hypertonic Saline and Dextran Versus Normal Saline [Phase 2, Phase 3]

View source ↗

Summary

A completed Phase 2/3 feasibility trial in the prehospital setting compared hypertonic saline with dextran to normal saline for traumatic brain injury.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Hypertonic saline with dextran (HTS-D) (Hypertonic saline with dextran; 3% saline with dextran 70)
  • Normal Saline (sodium chloride 0.9% solution)

Snippet

Sponsor: Unity Health Toronto | Conditions: Brain Injuries | Phase 2, Phase 3 | Status: COMPLETED